Swan Capital’s Globus Medical GMED Stock Holding History

Swan Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19K	Buy	+15	New	+$1.27K	﹤0.01%	432
2025 Q1	–	Sell	-10	Closed	-$827	–	401
2024 Q4	$827	Buy	+10	New	+$789	﹤0.01%	292

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Swan Capital's GMED Position: Q2 2026 in Review

Swan Capital opened a new position in Globus Medical (GMED) in Q2 2026: 15 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #432 among its holdings. This is a return to the name: Swan Capital previously reported a position in GMED as recently as Q4 2024.

Swan Capital first reported a position in GMED in Q4 2024 and has held it in 2 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Swan Capital held 15 shares of Globus Medical worth $1.19K as of Q2 2026.
Globus Medical was a new Swan Capital position in Q2 2026.
Globus Medical made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #432 holding.
Swan Capital first reported a position in Globus Medical in Q4 2024 and has held it in 2 quarters since.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.